MedTrace Logo

Acceptability of Fortified Bouillon Cubes in Northern Ghana

NCT05177614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2022-04-18

No results posted yet for this study

Summary

This study aims to evaluate the acceptability of bouillon cubes fortified with six micronutrients for which deficiency is common among women and children in Ghana and to assess the feasibility and reliability of data collection methods to be used in a planned, more detailed study to evaluate the effect of multiple micronutrient (MN)-fortified bouillon cube on biomarkers of nutrient status, health and development of women and children.

Conditions

  • Food, Fortified
  • Dietary Habits
  • Child Development

Interventions

DIETARY_SUPPLEMENT

Upper-level multiple micronutrient-fortified bouillon cube

80 µg/g Folic acid 1.2 µg/g Vitamin B12 3 mg/g Zinc (ZnO) 4 mg/g Iron (FePP/citric acid/trisodium citrate) 200 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)

DIETARY_SUPPLEMENT

Lower-level multiple micronutrient-fortified bouillon cube

28.8 µg/g Folic acid 0.288 µg/g Vitamin B12 1.68 mg/g Zinc (ZnO) 1.3 mg/g Iron (FePP/citric acid/trisodium citrate) 96 µg/g Vitamin A (retinyl palmitate) 30 µg/g Iodine (KIO3)

DIETARY_SUPPLEMENT

Iodine-fortified bouillon cube

30 µg/g Iodine (KIO3)

Sponsors & Collaborators

  • University of Ghana

    collaborator OTHER

  • Helen Keller International

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Reina Engle-Stone, PhD · University of California, Davis

  • Seth Adu-Afarwuah, PhD · University of Ghana

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-23
Primary Completion
2022-01-28
Completion
2022-01-28

Countries

  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05177614 on ClinicalTrials.gov